, Singapore

Sanofi to invest $638m in new Singapore vaccine production site

Construction is expected to begin in Q3 of 2021.

Biopharmaceutical company Sanofi is going to invest $638m (€400m) over five years to create a vaccine production centre in Singapore, in partnership with the Singapore Economic Development Board (EDB). The facility will supply vaccines to Asia and complement existing manufacturing capacities in Europe and North America.

The new site will provide Sanofi with the ability to produce vaccines on a massive scale for Asia, and quickly respond to future pandemic risks.

“As a major healthcare player, it’s our responsibility to act and to meet the unprecedented growing demands for vaccines. By investing in a new production site in Singapore, Sanofi is aiming to strengthen production capacity to meet ever-growing global demands on vaccines, and answer more rapidly to future pandemics,” said Thomas Triomphe, Executive Vice President and Global Head of Sanofi Pasteur.

The construction is expected to begin in Q3 2021, and is expected to be fully operational in Q1 2026, once all qualifications and validations have been completed.
 

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.